- Home
- KYN vs RXRX Comparison
KYN vs RXRX Comparison
Compare KYN & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYN
- RXRX
- Stock Information
- Founded
- KYN 2004
- RXRX 2013
- Country
- KYN United States
- RXRX United States
- Employees
- KYN N/A
- RXRX N/A
- Industry
- KYN Finance/Investors Services
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- KYN Finance
- RXRX Health Care
- Exchange
- KYN Nasdaq
- RXRX Nasdaq
- Market Cap
- KYN 2.0B
- RXRX 2.0B
- IPO Year
- KYN N/A
- RXRX 2021
- Fundamental
- Price
- KYN $12.61
- RXRX $5.25
- Analyst Decision
- KYN
- RXRX Buy
- Analyst Count
- KYN 0
- RXRX 5
- Target Price
- KYN N/A
- RXRX $7.00
- AVG Volume (30 Days)
- KYN 561.5K
- RXRX 32.1M
- Earning Date
- KYN 01-01-0001
- RXRX 08-07-2025
- Dividend Yield
- KYN 8.99%
- RXRX N/A
- EPS Growth
- KYN N/A
- RXRX N/A
- EPS
- KYN 0.71
- RXRX N/A
- Revenue
- KYN N/A
- RXRX $59,790,000.00
- Revenue This Year
- KYN N/A
- RXRX $23.51
- Revenue Next Year
- KYN N/A
- RXRX $53.87
- P/E Ratio
- KYN $13.79
- RXRX N/A
- Revenue Growth
- KYN N/A
- RXRX 29.32
- 52 Week Low
- KYN $7.84
- RXRX $3.79
- 52 Week High
- KYN $9.88
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- KYN 58.59
- RXRX 55.15
- Support Level
- KYN $12.45
- RXRX $4.91
- Resistance Level
- KYN $12.80
- RXRX $5.44
- Average True Range (ATR)
- KYN 0.19
- RXRX 0.36
- MACD
- KYN 0.02
- RXRX 0.01
- Stochastic Oscillator
- KYN 67.68
- RXRX 72.37
About KYN Kayne Anderson Energy Infrastructure Fund Inc.
Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.